36 results
PRER14A
BXRXQ
Baudax Bio, Inc.
25 Aug 23
Preliminary revised proxy
4:01pm
the subjects’ privacy. The IRB approves the information regarding the clinical trial and the consent form that must be provided to each clinical trial
DEFA14A
BXRXQ
Baudax Bio, Inc.
21 Aug 23
Additional proxy soliciting materials
8:05am
regulatory laws, including without limitation, laws related to fraud and abuse, payment transparency, and privacy and security of protected health … or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data
8-K
EX-10.1
BXRXQ
Baudax Bio, Inc.
21 Aug 23
Entry into a Material Definitive Agreement
8:00am
and foreign health care regulatory laws, including without limitation, laws related to fraud and abuse, payment transparency, and privacy and security … or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
DEFA14A
EX-99.1
BXRXQ
Baudax Bio, Inc.
9 Aug 23
Additional proxy soliciting materials
5:28pm
to ensure subject safety, and provisions to protect the subjects’ privacy. The IRB approves the information regarding the clinical trial and the consent
8-K/A
EX-99.1
hcgrqnn71vn1
9 Aug 23
Other Events
5:27pm
DEFA14A
hq1f3 e0bzhv7tg44ov
5 Jul 23
Additional proxy soliciting materials
5:28pm
8-K
EX-2.1
xw2ey
5 Jul 23
Entry into a Material Definitive Agreement
5:26pm
S-1/A
EX-10.35
94qi mnl1ks
16 Aug 22
IPO registration (amended)
9:07pm
8-K
EX-10.1
bs1kuk 1karszoe
18 May 22
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-1.1
ia8wijnuznbz8 qlp
1 Mar 22
Entry into a Material Definitive Agreement
7:01am
8-K
EX-10.1
boo1xsdvoepyvd
28 Dec 21
Entry into a Material Definitive Agreement
4:42pm
8-K
EX-10.1
ak0aq9x3
1 Jun 21
Entry into a Material Definitive Agreement
9:02am